Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib btd date 2023?Drugpatentwatch trametinib?Norcuron generic name?When will tenofovir alafenide come off patent in canada?Mebendazole for kids price?
See the DrugPatentWatch profile for gvoke
Gvoke is a liquid ready-to-use injection. It's a glucagon formulation administered via a prefilled syringe or autoinjector, with no reconstitution needed—unlike older powdered glucagon kits that require mixing with sterile water.[1]
Traditional glucagon (like GlucaGen) comes as a lyophilized powder in a vial, which must be dissolved before injection. Gvoke skips this step with its aqueous liquid solution, making it faster for emergency hypoglycemia treatment.[1][2]
The liquid form reduces errors in high-stress situations, like severe low blood sugar, where mixing powder can fail. FDA approved Gvoke in 2019 for this reason.[2] [1]: Gvoke Prescribing Information [2]: FDA Approval Summary
Other Questions About Gvoke :